Upadacitinib in Crohn's disease

  • Published on 04/02/2024
  •  Reading time: 4 min.

Axel Dignass a,* , Philip Esters a & Cathrin Flauaus b

a Department of Medicine I, Agaplesion Markus Hospital, Frankfurt/Main, Germany
b AbbVie Deutschland GmbH & Co. KG, Medical Immunology, Wiesbaden, Germany

CONTACT Axel Dignass mailto:Axel.Dignass@agaplesion.de Department of Medicine, Agaplesion Markus Hospital, Goethe University, Wilhelm-Epstein Str. 4, Frankfurt am Main 60431, Germany


To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Hepato Gastroenterology

Receive our newsletter to stay up to date with the latest news in Hepato Gastroenterology

More articles

From peer-reviewed journals in Hepato Gastroenterology